Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

Sovaldi image

Gilead sued over Sovaldi price

December 15, 2014
Sales and Marketing BMS, Gilead, NICE, harvoni, hep C, septa, sofosbuvir, sovaldi

A payer is suing Gilead over the price of its hep-c drug Sovaldi in the US after spending $2.4 million …

News
Janssen image

Patient access schemes ‘lack transparency’

December 12, 2014
Research and Development, Sales and Marketing Janssen, NHS, NICE, Velcade, patient access, pharma, scheme

Deals negotiated between the pharma industry and governments to allow patients access to innovative new cancer treatments risk failing because …

News

NICE changes insulin advice in diabetes guidelines

December 12, 2014
Sales and Marketing NHS, NICE, diabetes, health survey, insulin, type 1, type 2

NICE has changed its recommendations on type 1 diabetes in adults and children, and type 2 diabetes in children, to …

News
Tamoxifen image

Tamoxifen found to reduce breast cancer rates by 30%

December 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arimidex, NICE, anastrozole, astrazenea, breast cancer, tamoxifen

A study from Queen Mary University has demonstrated that tamoxifen can reduce breast cancer rates by around 30% over 20 …

News
NHS image

Labour to extend cancer drugs funding if elected

December 10, 2014
Research and Development, Sales and Marketing CDF, Cancer, Labour, NHS, NICE, andy burnham, election

Labour has committed to continuing the Cancer Drugs Fund system under the guise of a new £330 million ‘Cancer Treatment …

News
Janssen image

NICE U-turn over Janssen arthritis drug

December 9, 2014
Sales and Marketing Janssen, NHS, NICE, Stelara, arthritis, ustekinumab

NICE has reversed its decision on Janssen’s Stelara and is now recommending the active psoriatic arthritis drug. The pricing watchdog …

News

Government seeks stakeholder consultation over NICE

December 4, 2014
Sales and Marketing ABPI, NHS, NICE, UK, emms, freeman, government, ndpb

NICE stakeholders are being asked for their views on its future as part of the government’s ongoing review into the …

News

NICE recommends test to reduce antibiotic use

December 3, 2014
Sales and Marketing Antibiotics, GPs, NICE, UK, doctors, icl, pneumonia

NICE guidelines say GPs should use point of care blood tests to assess which patients to prescribe antibiotics for bacterial …

News
Roche image

NICE U-turn on Roche leukaemia drug

December 2, 2014
Sales and Marketing Gazyvaro, MabThera, NHS, NICE, Roche, leukaemia, obinutuzumab

NICE has reversed its decision on Roche’s chronic lymphocytic leukaemia (CLL) drug Gazyvaro only two months after rejecting the drug. …

News
Selincro image

Lundbeck’s alcohol pill given NICE approval

November 27, 2014
Sales and Marketing Lundbeck, NHS, NICE, alcohol, selincro

NICE has finally approved the use of Selincro (nalmefene) in order to help people who are dependent on alcohol cut …

News
Soliris image

NHS to get world’s most expensive drug

November 27, 2014
Sales and Marketing Alexion, NICE, aHUS, beauchamp, blood, eculizumab, soliris

UK health watchdog NICE has recommended Alexion’s Soliris for patients with the rare disease atypical haemolytic uremic syndrome (aHUS).  Soliris …

News
Mark Baker image

NICE aims for earlier cancer diagnosis

November 20, 2014
Sales and Marketing Cancer, England, NHS, NICE, OECD, UK, baker

NICE is updating its guidance in a bid to help doctors spot the signs and symptoms of cancer as part …

News

NICE wants more Xolair data

November 19, 2014
Sales and Marketing Genentech, NHS, NICE, Novartis, UK, Xolair, hives, omalizumab

 Novartis has been asked in draft guidance to give NICE more information before the watchdog can recommend its veteran asthma …

News

Cost of NHS medicines rises

November 14, 2014
Sales and Marketing HSCIC, NHS, NICE, PPRS, drugs, hospitals, spend

Hospitals in England are taking an increasing share of the NHS’s bill for drugs approved by NICE, according to a …

News
Breakthrough Breast Cancer's senior policy manager Caitlin Palframan image

Charity ‘deeply concerned’ on CDF changes

November 13, 2014
Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, breakthrough breast cancer, palframan

A leading cancer charity has warned that a number of key drugs are at risk of being withdrawn from patients …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026